Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the dermaPACE™ (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care in the Treatment of Diabetic Foot Ulcers

NCT00536744 is registered in ClinicalTrials.gov with SANUWAVE, Inc. as lead sponsor.

NCT NCT00536744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00536744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the dermaPACE™ (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care in the Treatment of Diabetic Foot Ulcers
Lead sponsor
SANUWAVE, Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2007
Completion date
September 30, 2010
Enrollment
206 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcers